1Yamanaka M, Watenabe M, Yamada Y, et al. Altered methylation of multiple genes in carcinogenesis of the prostate[J]. Int J Cancer,2003,106 ( 3 ) :382-387.
2Henrique R, Jeronimo C. Molecular detection of prostate cancer : a role for GSTPI hypermethylation[ J ]. European Urology, 2004,46(5) :660-669.
3Esteller M, Com PG, Urena JM, et al. Inactivation of glutathione D-transferase P1 gene by promoter hypermethylation in human neoplasia [J]. Cancer Res, 1998,58 ( 20 ) : 4515- 4518.
4Chan MW, Chan LW, Tang NI, et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients [J]. Clin Cancer Res, 2002,8 ( 2 ) : 464..470.
5Esteller M, Sparks A, Toyota M, et al. A gene hypermethylation profile of human cancer[J]. Cancer Res,2001,61 (8) : 3225 -3229.
6Tchou JC, Lin X Freije D, et al. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas [ J ]. Int J oncol,2000,16(4) :633-676.
7Woodson K, Hanson J, Tangrea J, et al. A survey of genespecitic methylation in human prostate cancer among black and white men [ J ]. Cancer Letters, 2004,205 ( 2 ) : 181 - 188.
8Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from lung tumor suppressor locus 3p21.3 [ J ]. Nat Genet, 2000,25 ( 3 ) : 315- 319.
9Kawamoto K, Okino ST, Place RF, et al. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer [ J ]. Clin Cancer Res, 2007,13 ( 9 ) : 2541- 2548.
10Virmani AK, Rathi A, Zochbauer-Muller S, et al. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas[J]. J Natl Cancer Inst, 2000, 92(16) : 1303-1310.
2Costello JF,Fruhwald MC,Smiraglia DJ.Aberrant CpG-island methylation has non-random and tumour-typy-specific patterns[J].Nat Genet,2000,24(2):132-138.
3Esteller M,Corn PG,Baylin SB,et al.A gene hypermethylation profile of human cancer[J].Cancer Res,2001,61 (8):3225-3229.
4Maruyama R,Toyooka S,Toyllka KO,et al.Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features[J].C lin Cancer Res,2002,8 (2):514-519.
5Graff JR,Herman JG,Lapidus RG,et al.E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas[J].Cancer Res,1995,55(22):5195-5199.
6Herman JG,Merlo A,Mao L,et al.Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers[J].Cancer Res,1995,55(20):4525-4530.
7Jarrard DF,Bova GS,Ewing CM,et al.Deletional,mutational and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer[J].Genes Chromosomes Cancer,1997,19(2):90-96.
8Li LC,Chui R,Nakajima K,et al.Frequent methylation of estrogen receptor in prostate cancer:correlation with tumor progression[J].Cancer Res,2000,60(3):702-706.
9Issa JP,Baylin SB,Belinsky SA.Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure[J].Cancer Res,1996,56 (16):3655-3658.
10Bonkhoff H,Fixemer T,Hunsicker I,et al.Estrogen receptor expression in prostate cancer and premalignant prostatic lesions[J].Am J Pathol,1999,155(2):641-647.
